Clinical Trials Directory

Trials / Completed

CompletedNCT05521919

Acute Plasma Abeta Responses to Stress

Effects of Acute Stress Exposure on Plasma Beta-amyloid Levels

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
38 (actual)
Sponsor
University of Southern California · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Research has shown that activation of the sympathetic nervous system for extended periods or during certain times in life can increase the risk for Alzheimer's disease. Some research in animal models show that acute activation of the sympathetic nervous system through stress exposure can increase certain Alzheimer's disease-related biomarkers, such as amyloid-beta, within hours of exposure. However, how acute sympathetic nervous system activation via stress exposure affects amyloid-beta levels in humans has yet to be examined. In this study, the investigators will examine whether brief increases in sympathetic activation result in immediate changes in plasma amyloid-beta levels in the five hours after exposure.

Detailed description

Aim 1: determine whether acute exposure to stress (increasing sympathetic nervous system activation) increases plasma amyloid-beta-40 and amyloid-beta-42 in the five hours following exposure.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSympathetic Nervous System ActivationParticipants will complete a task that increases sympathetic nervous system activation.
BEHAVIORALNo-stressParticipants will complete a task that will not affect their sympathetic nervous system activity.

Timeline

Start date
2023-12-05
Primary completion
2024-12-10
Completion
2024-12-10
First posted
2022-08-30
Last updated
2025-12-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05521919. Inclusion in this directory is not an endorsement.